Who is fooling us?

Comment

Jean-Jacques Mourad et al. Lancet. 2002.

. 2002 Jul 6;360(9326):89.

doi: 10.1016/S0140-6736(02)09348-0.

No abstract available

Comment in

Who is fooling us?
Sleight P, Yusuf S. Sleight P, et al. Lancet. 2002 Sep 14;360(9336):873-4. doi: 10.1016/S0140-6736(02)09974-9. Lancet. 2002. PMID: 12243941 No abstract available.

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group. PROGRESS Collaborative Group. Lancet. 2001 Sep 29;358(9287):1033-41. doi: 10.1016/S0140-6736(01)06178-5. Lancet. 2001. PMID: 11589932 Clinical Trial.
Blood-pressure reduction and cardiovascular risk in HOPE study.
Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J; Heart Outcomes Prevention Evaluation (HOPE) Study. Sleight P, et al. Lancet. 2001 Dec 22-29;358(9299):2130-1. doi: 10.1016/S0140-6736(01)07186-0. Lancet. 2001. PMID: 11784631